Trials / Unknown
UnknownNCT04134169
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis : 5-year Results From the K0202 Extension Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (estimated)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Detailed description
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid arthritis: 5-year Results From the K0202 Extension Study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable(observational study) | Not applicable(observational study) |
Timeline
- Start date
- 2019-10-02
- Primary completion
- 2025-08-11
- Completion
- 2026-04-11
- First posted
- 2019-10-22
- Last updated
- 2022-10-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04134169. Inclusion in this directory is not an endorsement.